BALDUCCI, Anna Giulia
 Distribuzione geografica
Continente #
NA - Nord America 797
EU - Europa 796
AS - Asia 345
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.944
Nazione #
US - Stati Uniti d'America 790
CN - Cina 265
IE - Irlanda 224
SE - Svezia 173
FI - Finlandia 164
IT - Italia 78
DE - Germania 70
TR - Turchia 49
UA - Ucraina 28
FR - Francia 23
IN - India 21
GB - Regno Unito 13
BE - Belgio 7
CA - Canada 7
ES - Italia 7
JP - Giappone 6
AT - Austria 4
NL - Olanda 3
SG - Singapore 2
AU - Australia 1
BR - Brasile 1
BT - Bhutan 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
ZA - Sudafrica 1
Totale 1.944
Città #
Dublin 224
Chandler 197
Dearborn 84
Ashburn 59
Beijing 52
Jacksonville 52
Izmir 49
Nanjing 49
Princeton 38
Parma 33
Wilmington 32
Bremen 27
Ann Arbor 16
Helsinki 16
Nanchang 15
Hebei 14
Pune 14
Milan 13
Hefei 12
San Mateo 12
Shanghai 12
Kunming 11
Jiaxing 10
Shenyang 10
Changsha 8
Guangzhou 7
Santiago De Compostela 7
Tianjin 7
Falls Church 6
Jinan 6
London 6
New York 6
Norwalk 6
Brussels 5
Toronto 5
Formigine 4
Fuzhou 4
Philadelphia 4
Southend 4
Vienna 4
Chennai 3
Düsseldorf 3
Pioltello 3
Seattle 3
Taizhou 3
Zhengzhou 3
Boardman 2
Chicago 2
Des Moines 2
Fremont 2
Grafing 2
Houston 2
Mestre 2
Montefiore dell'Aso 2
Ningbo 2
Osaka 2
Rockville 2
Simi Valley 2
Wenzhou 2
Alghero 1
Amsterdam 1
Bielefeld 1
Borås 1
Brno 1
Castenaso 1
Chengdu 1
Chongqing 1
Dalian 1
Fayetteville 1
Geislingen an der Steige 1
Godhra 1
Hangzhou 1
Islington 1
Johannesburg 1
Liège 1
Luton 1
Melbourne 1
Montréal 1
Mountain View 1
North Bergen 1
Padova 1
Plesnoy 1
Puxian 1
Saronno 1
Sault Ste. Marie 1
Scottsdale 1
Selargius 1
Shaoxing 1
Shenzhen 1
Szeged 1
São Paulo 1
Taiyuan 1
Thimphu 1
Vercelli 1
Vigevano 1
Washington 1
Wuhan 1
Wurzen 1
Xian 1
Totale 1.224
Nome #
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 93
Solid-state characterization of tobramycin powders for inhalation 91
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 68
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 67
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 66
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 66
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 66
Brain distribution of ribavirin after intranasal administration 65
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 63
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 62
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 60
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 60
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 59
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 57
Layered lipid microcapsules for mesalazine delayed-release in children 55
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 55
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers 52
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 51
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 49
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 49
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 49
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 49
Influence of Sodium Stearate on Amikacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Patients with Pseudomonas Aeruginosa Lung Infections 49
Liposome sensing and monitoring by organic electrochemical transistors integrated in microfluidics 48
Performance of Different Nebulizers in the Aerosolization of Colistimethate Sodium 48
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 48
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the in Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler 47
Dry Coating Technique for Inhalation Powders 47
The Influence of Energy Input During Dry Powder Blending on Dynamic Flow Properties, Powder Aerosolization and Dissolution of Dry Powders for Inhalation 45
Treatment of equine sarcoids 44
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients 43
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 42
Drug Delivery Strategies for Pulmonary Administration of Antibiotics 40
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 39
PREPARATION OF SOFT AGGLOMERATES BASED ON ARTEMISININ-βCD COMPLEXES 37
Polymeric Films Loaded with Vitamin E and Aloe vera for Topical Application in the Treatment of Burn Wounds 35
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment—A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 29
Patent Foramen Ovale Related Cryptogenic Stroke during COVID-19 Disease in Three Patients: A Case Series 28
Totale 2.021
Categoria #
all - tutte 6.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 5 63 3
2019/2020393 91 71 16 5 19 70 49 7 12 30 10 13
2020/202187 0 8 5 3 15 1 8 1 33 1 11 1
2021/2022135 2 2 0 2 4 6 12 15 9 10 4 69
2022/2023762 67 109 45 49 65 75 1 57 269 1 24 0
2023/2024190 16 33 6 8 20 58 28 11 3 7 0 0
Totale 2.021